# Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery

> **NCT06745492** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 59 (actual)

## Conditions studied

- Recovery Time

## Interventions

- **DRUG:** Neostigmine + Glycopyrrolate

## Key facts

- **NCT ID:** NCT06745492
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2023-08-20
- **Final completion:** 2023-08-25
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06745492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06745492, "Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06745492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*